Bevacizumab has been sold as Avastin by originator Roche for many years and used by the NHS for various forms of cancer, with ...

Susan Galbraith, AstraZeneca’s executive vice president for oncology haematology R&D, discussed the setback in a statement. Galbraith said the goal was to “reinvigorate the immune response of patients ...

NDA supported by positive Phase II registration study data in Chinese patients; follows Breakthrough Therapy Designation granted in 2023 —— ...

Several new laws in Virginia regarding social media, baby food, and healthcare take effect on January 1. Social media ...

Manulife Hong Kong today announced an expansion of its partnership with Hong Kong Baptist Hospital (HKBH) through the launch ...

According to a rumor that circulated online in late 2025, Speaker of the House Mike Johnson, R-La., gives away nearly all his ...

Looking back at 365 days seems daunting at first, but as you browse through photos, articles, and your own memories, there ...

When compiling our list of the best stocks to buy now, we look for high-quality companies that are poised to benefit over the ...

With a new study in the journal Science Bulletin, researchers at Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University have discovered a new way that aggressive breast cancer cells escape the immune ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...

A recent study published in Engineering has shed light on the potential therapeutic effects of dihydrotanshinone I (DHT), a ...